The role of microRNA in the response to cisplatin treatment

Biochemical Society Transactions

Volumn 40, Issue 4, 2012, Pages 821-825

  Drayton, Ross M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cisplatin; microRNA (miRNA); Protein expression; Tumour

Indexed keywords

ATM PROTEIN; CARRIER PROTEIN; CISPLATIN; CTR1 PROTEIN; DICER; DNA; KH TYPE SPLICING REGULATORY PROTEIN; MENKES PROTEIN; MICRORNA; MICRORNA 181A; MICRORNA 192; MICRORNA 194; MICRORNA 215; MICRORNA 34A; MICRORNA 374A; MICRORNA 519A; MICRORNA 630; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; PROTEIN P63; REGULATOR PROTEIN; RNA POLYMERASE II; STAT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WILSON DISEASE PROTEIN;

3' UNTRANSLATED REGION; APOPTOSIS; AUTOPHAGY; CANCER RESISTANCE; CONFERENCE PAPER; DNA DAMAGE CHECKPOINT; DNA METHYLATION; DOWN REGULATION; DRUG DETOXIFICATION; DRUG RESPONSE; DRUG TRANSPORT; ENZYME ACTIVATION; EPIGENETICS; HUMAN; MEDULLOBLASTOMA; NONHUMAN; PHARMACOGENETICS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; RNA PROCESSING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; MICRORNAS;

EID: 84864383181     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120055     Document Type: Conference Paper

References (53)

1. Rosenberg, B., Vancamp, L. and Krigas, T. (1965) Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205, 698-699
2. Kelland, L. (2007) The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7, 573-584
3. Stewart, D.J. (2007) Mechanisms of resistance to cisplatin and carboplatin. Crit. Rev. Oncol. Hematol. 63, 12-31
4. Koberle, B., Tomicic, M.T., Usanova, S. and Kaina, B. (2010) Cisplatin resistance: preclinical findings and clinical implications. Biochim. Biophys. Acta 1806, 172-182
5. Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854 (Pubitemid 24014542)
6. Reinhart, B.J., Weinstein, E.G., Rhoades, M.W., Bartel, B. and Bartel, D.P. (2002) MicroRNAs in plants. Genes Dev. 16, 1616-1626 (Pubitemid 34743323)
7. Pasquinelli, A.E., Reinhart, B.J., Slack, F., Martindale, M.Q., Kuroda, M.I., Maller, B., Hayward, D.C., Ball, E.E., Degnan, B., Muller, P. et al. (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86-89
8. Lewis, B.P., Shih, I.H., Jones-Rhoades, M.W., Bartel, D.P. and Burge, C.B. (2003) Prediction of mammalian microRNA targets. Cell 115, 787-798 (Pubitemid 38058492)
9. Lim, L.P., Lau, N.C., Garrett-Engele, P., Grimson, A., Schelter, J.M., Castle, J., Bartel, D.P., Linsley, P.S. and Johnson, J.M. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773 (Pubitemid 40292988)
10. Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H. and Kim, V.N. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060 (Pubitemid 39472426)
11. Corcoran, D.L., Pandit, K.V., Gordon, B., Bhattacharjee, A., Kaminski, N. and Benos, P.V. (2009) Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data. PLoS ONE 4, e5279
12. Bhatt, K., Zhou, L., Mi, Q.S., Huang, S., She, J.X. and Dong, Z. (2010) MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. Mol. Med. 16, 409-416
13. Braun, C.J., Zhang, X., Savelyeva, I., Wolff, S., Moll, U.M., Schepeler, T., Orntoft, T.F., Andersen, C.L. and Dobbelstein, M. (2008) p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 68, 10094-10104
14. Hibi, K., Trink, B., Patturajan, M., Westra, W.H., Caballero, O.L., Hill, D.E., Ratovitski, E.A., Jen, J. and Sidransky, D. (2000) AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 97, 5462-5467 (Pubitemid 30313741)
15. Huang, Y., Chuang, A., Hao, H., Talbot, C., Sen, T., Trink, B., Sidransky, D. and Ratovitski, E. (2011) Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells. Cell Death Differ. 18, 1220-1230
16. Yu, W., Jin, C., Lou, X., Han, X., Li, L., He, Y., Zhang, H., Ma, K., Zhu, J., Cheng, L. et al. (2011) Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell. PLoS ONE 6, e29450
17. Wermann, H., Stoop, H., Gillis, A.J., Honecker, F., van Gurp, R.J., Ammerpohl, O., Richter, J., Oosterhuis, J.W., Bokemeyer, C. and Looijenga, L.H. (2010) Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance. J. Pathol. 221, 433-442
18. Plumb, J.A., Strathdee, G., Sludden, J., Kaye, S.B. and Brown, R. (2000) Reversal of drug resistance in human tumor xenografts by 2′-deoxy-5- azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res. 60, 6039-6044
19. Yang, C., Cai, J., Wang, Q., Tang, H., Cao, J., Wu, L. and Wang, Z. (2012) Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. Gynecol. Oncol. 124, 325-334
20. Trabucchi, M., Briata, P., Garcia-Mayoral, M., Haase, A.D., Filipowicz, W., Ramos, A., Gherzi, R. and Rosenfeld, M.G. (2009) The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459, 1010-1014
21. Zhang, G., Sun, L., Lu, X., Chen, Z., Duerksen-Hughes, P.J., Hu, H., Zhu, X. and Yang, J. (2012) Cisplatin treatment leads to changes in nuclear protein and microRNA expression. Mutat. Res. 746, 66-77
22. Bernstein, E., Caudy, A.A., Hammond, S.M. and Hannon, G.J. (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366 (Pubitemid 32151243)
23. Chiosea, S., Jelezcova, E., Chandran, U., Acquafondata, M., McHale, T., Sobol, R.W. and Dhir, R. (2006) Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am. J. Pathol. 169, 1812-1820 (Pubitemid 351182010)
24. Chiosea, S., Jelezcova, E., Chandran, U., Luo, J., Mantha, G., Sobol, R.W. and Dacic, S. (2007) Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res. 67, 2345-2350 (Pubitemid 46424256)
25. Bu, Y., Lu, C., Bian, C., Wang, J., Li, J., Zhang, B., Li, Z., Brewer, G. and Zhao, R.C. (2009) Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatin. Oncol. Rep. 21, 13-17
26. Hedman, H.K., Kirpekar, F. and Elmroth, S.K. (2011) Platinum interference with siRNA non-seed regions fine-tunes silencing capacity. J. Am. Chem. Soc. 133, 11977-11984
27. Ishida, S., Lee, J., Thiele, D.J. and Herskowitz, I. (2002) Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc. Natl. Acad. Sci. U.S.A. 99, 14298-14302 (Pubitemid 35257666)
28. Samimi, G., Katano, K., Holzer, A.K., Safaei, R. and Howell, S.B. (2004) Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. Mol. Pharmacol. 66, 25-32 (Pubitemid 38822084)
29. Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z.S., Terada, K., Furukawa, T., Yang, X.L., Gao, H., Miura, N., Sugiyama, T. et al. (2000) Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 60, 1312-1316 (Pubitemid 30152000)
30. Siddik, Z.H. (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279
31. Pogribny, I.P., Filkowski, J.N., Tryndyak, V.P., Golubov, A., Shpyleva, S.I. and Kovalchuk, O. (2010) Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int. J. Cancer 127, 1785-1794
32. Guo, L., Liu, Y., Bai, Y., Sun, Y., Xiao, F. and Guo, Y. (2010) Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Eur. J. Cancer 46, 1692-1702
33. Zou, Z., Wu, L., Ding, H., Wang, Y., Zhang, Y., Chen, X., Zhang, C.Y., Zhang, Q. and Zen, K. (2012) MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy. J. Biol. Chem. 287, 4148-4156
34. Sorrentino, A., Liu, C.G., Addario, A., Peschle, C., Scambia, G. and Ferlini, C. (2008) Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol. Oncol. 111, 478-486
35. Toy, E.P., Chambers, J.T., Kacinski, B.M., Flick, M.B. and Chambers, S.K. (2001) The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma. Gynecol. Oncol. 80, 194-200 (Pubitemid 32158458)
36. Ye, G., Fu, G., Cui, S., Zhao, S., Bernaudo, S., Bai, Y., Ding, Y., Zhang, Y., Yang, B.B. and Peng, C. (2011) MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance. J. Cell Sci. 124, 359-368
37. Weeraratne, S.D., Amani, V., Neiss, A., Teider, N., Scott, D.K., Pomeroy, S.L. and Cho, Y.J. (2011) miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro-Oncol. 13, 165-175
38. Donzelli, S., Fontemaggi, G., Fazi, F., Di Agostino, S., Padula, F., Biagioni, F., Muti, P., Strano, S. and Blandino, G. (2012) MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function. Cell Death Differ. 19, 1038-1048
39. Sun, L., Yao, Y., Liu, B., Lin, Z., Lin, L., Yang, M., Zhang, W., Chen, W., Pan, C., Liu, Q. et al. (2012) miR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 31, 432-445
40. Ru, P., Steele, R., Hsueh, E.C. and Ray, R.B. (2011) Anti-miR-203 upregulates SOCS3 expression in breast cancer cells and enhances cisplatin chemosensitivity. Genes Cancer 2, 720-727
41. Fu, X., Tian, J., Zhang, L., Chen, Y. and Hao, Q. (2012) Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett. 586, 1279-1286
42. Peng, D.J., Wang, J., Zhou, J.Y. and Wu, G.S. (2010) Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells. Biochem. Biophys. Res. Commun. 394, 600-605
43. Yang, H., Kong, W., He, L., Zhao, J.J., O'Donnell, J.D., Wang, J., Wenham, R.M., Coppola, D., Kruk, P.A., Nicosia, S.V. et al. (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68, 425-433 (Pubitemid 351380068)
44. Hamano, R., Miyata, H., Yamasaki, M., Kurokawa, Y., Hara, J., Moon, J.H., Nakajima, K., Takiguchi, S., Fujiwara, Y., Mori, M. et al. (2011) Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res. 17, 3029-3038
45. Ceppi, P., Mudduluru, G., Kumarswamy, R., Rapa, I., Scagliotti, G.V., Papotti, M. and Allgayer, H. (2010) Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol. Cancer Res. 8, 1207-1216
46. Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J. and Fan, D. (2008) miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 123, 372-379 (Pubitemid 351842022)
47. Zhu, W., Xu, H., Zhu, D., Zhi, H., Wang, T., Wang, J., Jiang, B., Shu, Y. and Liu, P. (2012) miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother. Pharmacol. 69, 723-731
48. Zhu, W., Zhu, D., Lu, S., Wang, T., Wang, J., Jiang, B., Shu, Y. and Liu, P. (2012) miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med. Oncol. 29, 384-391
49. Bagnoli, M., De Cecco, L., Granata, A., Nicoletti, R., Marchesi, E., Alberti, P., Valeri, B., Libra, M., Barbareschi, M., Raspagliesi, F. et al. (2011) Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget 2, 1265-1278
50. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'Briant, K.C., Allen, A. et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518
51. Zhu, W., Shan, X., Wang, T., Shu, Y. and Liu, P. (2010) miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J. Cancer 127, 2520-2529
52. Bian, H.B., Pan, X., Yang, J.S., Wang, Z.X. and De, W. (2011) Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549). J. Exp. Clin. Cancer Res. 30, 20
53. Yang, N., Kaur, S., Volinia, S., Greshock, J., Lassus, H., Hasegawa, K., Liang, S., Leminen, A., Deng, S., Smith, L. et al. (2008) MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 68, 10307-10314